Study of CS-3150 in Patients With Essential Hypertension

NCT02890173 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1001

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: CS-3150
DRUG: Eplerenone

Sponsor

Daiichi Sankyo Co., Ltd.